Product NDC: | 21695-954 |
Proprietary Name: | TREXIMET |
Non Proprietary Name: | sumatriptan succinate and naproxen sodium |
Active Ingredient(s): | 500; 85 mg/1; mg/1 & nbsp; sumatriptan succinate and naproxen sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-954 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021926 |
Marketing Category: | NDA |
Start Marketing Date: | 20080425 |
Package NDC: | 21695-954-09 |
Package Description: | 9 TABLET, FILM COATED in 1 CONTAINER (21695-954-09) |
NDC Code | 21695-954-09 |
Proprietary Name | TREXIMET |
Package Description | 9 TABLET, FILM COATED in 1 CONTAINER (21695-954-09) |
Product NDC | 21695-954 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sumatriptan succinate and naproxen sodium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20080425 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE |
Strength Number | 500; 85 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |